Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26^th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024.

Details of the event are as follows:
Fireside Chat Date and Time: Monday, September 9, 2024, at 12:30 p.m. ET

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact:
Christopher James, M.D.                                                                                       
Vice President, Investor Relations
[email protected] 

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
[email protected] 

You May Also Be Interested In

• Borealis Foods Inc. Receives Expected Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q for Fiscal Quarter Ended June 30, 2026
• PRSA-NY Announces 2026 Individual Honorees for the Big Apple Awards
• Plaza Tire Service Opens New Bowling Green Location on Campbell Lane